Friday, April 15, 2022 12:42:02 PM
Fri, April 15, 2022, 9:10 AM
IRVINE, CA / ACCESSWIRE / April 15, 2022 / ORHub, Inc. (OTC Pink:ORHB) announced today it has reached a Definitive Agreement and successfully completed its due diligence of PUR Biologics, LLC.
"While FutureORTM digitizes the payment process & implant accountability for PUR product sales, our goal is to replace the dated use of cortisone, lubricants, and other temporary injectables with PUR's regenerative and anti-inflammatory technologies," shared CJ Wiggins - Founder, Executive Chairman, President & CEO for ORHub.
"Healthcare is evolving and adopting digital business and biologic clinical solutions which have proven value for their organizations and patient outcomes. PUR's advanced technologies bring the opportunity to address a largely unmet patient need associated with aging or injured joints. We believe these types of technologies can eliminate pain signals and restore damaged tissue or degenerated cartilage - ultimately improving functional outcomes and the quality of an active life."
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM